Restore Vision Secures 1.3 Billion Yen in Pre-Series B Funding to Advance Gene Therapy for Vision Restoration#Japan#Tokyo#gene_therapy#Restore_Vision#RV-001
Restore Vision Secures 1.3 Billion Yen in Pre-Series B Funding to Advance Gene Therapy for Vision Restoration
Restore Vision has successfully raised 1.3 billion yen in Pre-Series B funding, aimed at accelerating global development of its RV-001 gene therapy to restore vision.
third-news.com
April 15, 2026 at 7:19 AM
Restore Vision Secures 1.3 Billion Yen in Pre-Series B Funding to Advance Gene Therapy for Vision Restoration#Japan#Tokyo#gene_therapy#Restore_Vision#RV-001
Info in "Alt" code in picture. #vajrayana #restore_vision #tantra #drikung
Dear Sangha and friends,
On Tuesday, December 30th, 2025 at 1:30pm PST (Pacific Daylight Time), Lama Jigme Rinpoche will be holding a Zoom session to give the transmission and teaching of "Vision-Restoring Avalokiteśvara".
Dear Sangha and friends,
On Tuesday, December 30th, 2025 at 1:30pm PST (Pacific Daylight Time), Lama Jigme Rinpoche will be holding a Zoom session to give the transmission and teaching of "Vision-Restoring Avalokiteśvara".
December 16, 2025 at 12:21 AM
Info in "Alt" code in picture. #vajrayana #restore_vision #tantra #drikung
Dear Sangha and friends,
On Tuesday, December 30th, 2025 at 1:30pm PST (Pacific Daylight Time), Lama Jigme Rinpoche will be holding a Zoom session to give the transmission and teaching of "Vision-Restoring Avalokiteśvara".
Dear Sangha and friends,
On Tuesday, December 30th, 2025 at 1:30pm PST (Pacific Daylight Time), Lama Jigme Rinpoche will be holding a Zoom session to give the transmission and teaching of "Vision-Restoring Avalokiteśvara".
Restore Vision Reveals Promising Clinical Interim Results for Revolutionary Gene Therapy RV-001#Japan#Tokyo#gene_therapy#Restore_Vision#RV-001
Restore Vision Reveals Promising Clinical Interim Results for Revolutionary Gene Therapy RV-001
Restore Vision announces significant interim clinical findings for RV-001, its innovative gene therapy for retinitis pigmentosa, showing promise in restoring vision.
third-news.com
May 1, 2026 at 6:33 AM
Restore Vision Reveals Promising Clinical Interim Results for Revolutionary Gene Therapy RV-001#Japan#Tokyo#gene_therapy#Restore_Vision#RV-001
First Patient Receives RV-001 in Pioneering Gene Therapy Trial for Retinitis Pigmentosa#Japan#Tokyo#Restore_Vision#RV-001#retinitis_pigmentosa
First Patient Receives RV-001 in Pioneering Gene Therapy Trial for Retinitis Pigmentosa
Restore Vision has successfully dosed the first patient in a groundbreaking Phase I/II trial of RV-001, addressing vision loss in retinitis pigmentosa.
third-news.com
February 13, 2025 at 7:06 AM
First Patient Receives RV-001 in Pioneering Gene Therapy Trial for Retinitis Pigmentosa#Japan#Tokyo#Restore_Vision#RV-001#retinitis_pigmentosa